Cargando…
Autophagy in the Central Nervous System and Effects of Chloroquine in Mucopolysaccharidosis Type II Mice
Mucopolysaccharidosis type II (MPS II) is a rare lysosomal storage disease (LSD) involving a genetic error in iduronic acid-2-sulfatase (IDS) metabolism that leads to accumulation of glycosaminoglycans within intracellular lysosomes. The primary treatment for MPS II, enzyme replacement therapy, is n...
Autores principales: | Maeda, Mitsuyo, Seto, Toshiyuki, Kadono, Chiho, Morimoto, Hideto, Kida, Sachiho, Suga, Mitsuo, Nakamura, Motohiro, Kataoka, Yosky, Hamazaki, Takashi, Shintaku, Haruo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928680/ https://www.ncbi.nlm.nih.gov/pubmed/31757021 http://dx.doi.org/10.3390/ijms20235829 |
Ejemplares similares
-
Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II
por: Seo, Joo-Hyun, et al.
Publicado: (2021) -
A Device for Ribbon Collection for Array Tomography with Scanning Electron Microscopy
por: Koike, Taro, et al.
Publicado: (2017) -
Periventricular heterotopia and white matter abnormalities in a girl with mosaic ring chromosome 6
por: Nishigaki, Satsuki, et al.
Publicado: (2015) -
Real world long-term outcomes in patients with mucopolysaccharidosis type II: A retrospective cohort study
por: Tomita, Kazuyoshi, et al.
Publicado: (2021) -
Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice
por: Kida, Sachiho, et al.
Publicado: (2023)